Dr. Lianne Simone Gensler, MD

Dr. Gensler practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Gensler's NPI, 1780781369, was assigned on September 17, 2006. Dr. Gensler graduated from UC Irvine School of Medicine in 2001. Dr. Gensler holds California license A83162.

Dr. Gensler's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Gensler's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Gensler to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gensler practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Gensler's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Gensler is board certified in rheumatology by the American Board of Internal Medicine. Dr. Gensler is licensed in California.

Dmand AI lists lupus among the conditions Dr. Gensler treats.

CMS data shows 121 Medicare services from Dr. Gensler across 3 procedure codes in 2024, for 42 Medicare patients. Medicare paid $8,047 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Gensler in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have arthritis, and 57% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gensler's median patient age at 54, with 40% women.

In 2024, Dr. Gensler wrote 405 Medicare Part D claims for 40 patients. CMS names the drug for 293 of them, across 15 drugs with 11 or more claims each, at $1,067,940 in total drug cost. In 2023, CMS named 311 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Gensler for performance year 2024, reported as part of a group. Dr. Gensler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gensler as offering telehealth.

Dmand AI links 138 papers to Dr. Gensler, published from 2011 to 2025. 2022 was the busiest year, with 18. The most frequent topics are Spondylitis, Ankylosing, Spondylarthritis and Antirheumatic Agents. Dr. Gensler has published most often in Ann Rheum Dis. Dr. Gensler's most frequent co-authors are John D. Reveille, MD, Jean W. Liew, MD and Philip J. Mease, MD.

Dmand AI links Dr. Gensler to 1 clinical trial. Conditions studied include Spondylitis, Ankylosing and Axial Spondyloarthritis.

CMS Open Payments shows 308 general payments to Dr. Gensler from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. UCB, Inc. paid the most, $197,406. It also lists 56 research payments totaling $85,658 from 2018 to 2024.

Dmand AI lists 2 awards for Dr. Gensler, most recently CMS Stage 1 EHR in 2013.

Dr. Gensler graduated from UC Irvine School of Medicine in 2001. Dr. Gensler is a member of AOA.

Dr. Gensler is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.